Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2023
About
Suggestions
Contact Us
4-((6-(2-(4-(4-((4-(3-acrylamidophenoxy)-5-chloropyrimidin-2-yl)amino)-3-methoxyphenyl)piperazin-1-yl)acetoxy)hexyl)oxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide
MeSH Supplementary Concept Data 2024
Details
Concepts
MeSH Supplementary
4-((6-(2-(4-(4-((4-(3-acrylamidophenoxy)-5-chloropyrimidin-2-yl)amino)-3-methoxyphenyl)piperazin-1-yl)acetoxy)hexyl)oxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide
Unique ID
C582928
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C582928
Pharm Action
Antineoplastic Agents
Registry Number
0
Heading Mapped to
*Oxadiazoles
*Pyrimidines
Frequency
1
Note
structure in first source
Source
J Med Chem. 2013 Jun 13;56(11):4738-48.
Indexing Information
ErbB Receptors
Date of Entry
2013/08/18
Revision Date
2018/09/24
Expand All
Collapse All
4-((6-(2-(4-(4-((4-(3-acrylamidophenoxy)-5-chloropyrimidin-2-yl)amino)-3-methoxyphenyl)piperazin-1-yl)acetoxy)hexyl)oxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide
Preferred
Concept UI
M0587058
Registry Number
0
Terms
4-((6-(2-(4-(4-((4-(3-acrylamidophenoxy)-5-chloropyrimidin-2-yl)amino)-3-methoxyphenyl)piperazin-1-yl)acetoxy)hexyl)oxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide
Preferred Term
Term UI
T848088
Date
08/18/2013
LexicalTag
NON
ThesaurusID
NLM (2014)
page delivered in 0.005s